<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02657707</url>
  </required_header>
  <id_info>
    <org_study_id>CL11003</org_study_id>
    <nct_id>NCT02657707</nct_id>
  </id_info>
  <brief_title>Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis</brief_title>
  <official_title>Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Microvention-Terumo, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Microvention-Terumo, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, multicenter, single-arm, open label clinical study to evaluate the safety and
      effectiveness of MicroVention, Inc. Roadsaver™ Carotid Stent System used in conjunction with
      the Nanoparasol® embolic protection system for the treatment of carotid artery stenosis in
      patients with elevated risk for adverse events following carotid endarterectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 295 patients will be enrolled for this study. All potential patients being
      considered for the study should have been diagnosed with significant carotid artery stenosis
      and be considered a high perioperative risk for carotid endarterectomy.

      Patients will be evaluated through screening, pre-procedure, index procedure, post-procedure.
      Follow-up visits will be completed at 30 days, 6 months, and 12, 24, and 36 months
      post-procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All stroke, death, and MI</measure>
    <time_frame>At 30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ipsilateral stroke</measure>
    <time_frame>At 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Successful deployment of stent</measure>
    <time_frame>Procedure day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Successful completion of procedure</measure>
    <time_frame>Procedure day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Successful deployment and retrieval of embolic protection device</measure>
    <time_frame>Procedure day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization (TLR)</measure>
    <time_frame>At 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-stent restenosis</measure>
    <time_frame>At 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major stroke</measure>
    <time_frame>At 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minor stroke</measure>
    <time_frame>At 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transient ischemic attack (TIA)</measure>
    <time_frame>Within 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurologic death</measure>
    <time_frame>At 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">295</enrollment>
  <condition>Carotid Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>Single-arm, open label</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To evaluate the safety and effectiveness of MicroVention, Inc. Roadsaver™ Carotid Stent System used in conjunction with the Nanoparasol® embolic protection system for the treatment of carotid artery stenosis in patients with elevated risk for adverse events following carotid endarterectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Roadsaver™ Carotid Artery Stent Device</intervention_name>
    <description>The Roadsaver™ carotid artery stent system is indicated for use in patients with significant atherosclerotic disease of the carotid arteries.</description>
    <arm_group_label>Single-arm, open label</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nanoparasol® Embolic Protection System</intervention_name>
    <description>The Nanoparasol® embolic protection system is indicated for use with a guidewire to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries.</description>
    <arm_group_label>Single-arm, open label</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is between &gt;21 and ≤80 years of age.

          2. Patient is willing and capable of complying with all study protocol requirements,
             including specified follow-up period and can be contacted by telephone.

          3. Patient or authorized legal representative is willing to provide written informed
             consent prior to enrollment in study.

          4. Patient should have been diagnosed with carotid artery stenosis and be considered a
             high operative risk for carotid endarterectomy.

          5. Patient is either:

               -  Symptomatic with carotid stenosis ≥50% as determined by angiography using NASCET
                  methodology. Symptomatic is defined as amaurosis fugax ipsilateral to the carotid
                  lesion; TIA or non-disabling stroke within 180 days of the procedure within the
                  hemisphere supplied by the target vessel; or

               -  Asymptomatic with carotid stenosis ≥80% as determined by angiography using NASCET
                  methodology.

          6. Patient has a target lesion located at the carotid bifurcation and/or proximal ICA.

          7. Patient has a single de novo or restenotic (post CEA) target lesion or severe tandem
             lesions close enough that can be covered by a single Roadsaver™ stent.

          8. Patients having a vessel with reference diameters between 3.0 mm and 9.0 mm at the
             target lesion.

        High Risk Inclusion Criteria

        For inclusion in the study, a patient must qualify in at least one anatomic or co-morbid
        high-risk condition, as shown below:

        Anatomic High Risk Conditions:

          1. Patient has a target lesion at or above the second vertebral body (level of jaw) or
             below the clavicle.

          2. Patient has an inability to extend the head due to cervical arthritis or other
             cervical disorders.

          3. Patient is status/post radiation therapy to the neck.

          4. Patient has a prior head and neck surgery in the region of the carotid artery.

          5. Patient has spinal immobility of the neck.

          6. Patient has the presence of tracheostomy stoma.

          7. Patient has laryngeal palsy or laryngectomy.

          8. Patient has a hostile neck or surgically inaccessible lesion.

          9. Patient has severe tandem lesions.

        Co-morbid High Risk Conditions:

          1. Patient is ≥70 years of age (maximum 80 years) at the time of enrollment.

          2. Patient has NYHA Class III or IV congestive heart failure (CHF) with LVEF &lt;35%.

          3. Patient has chronic obstructive pulmonary disease (COPD) with FEV &lt;30%.

          4. Patient has unstable angina.

          5. Patient has had a recent myocardial infarction (≥30 days prior to stenting procedure).

          6. Patient has coronary artery disease with two or more vessels with ≥ 70% stenosis.

          7. Patient has planned CABG or valve replacement surgery between 31‐60 days after the CAS
             procedure.

          8. Patient requires peripheral vascular surgery or abdominal aortic aneurysm repair
             between 31‐60 days following the CAS procedure.

          9. Patient has contralateral laryngeal nerve paralysis

         10. Patient has restenosis after a previous CEA.

         11. Patient has contralateral occlusion in the ICA as the only comorbid high risk
             condition.

        Exclusion Criteria:

          1. Patient has life expectancy of less than one year.

          2. Patient is experiencing (or has experienced) an evolving, acute, or recent disabling
             stroke in the last 30 days.

          3. Patient has anticipated or potential sources of emboli (e.g. known previously
             symptomatic patent foramen ovale (PFO), mechanical heart valve, or deep vein
             thrombosis (DVT) treated within 6 months) that are not adequately treated with
             antithrombotics for at least two weeks with documented coagulation parameters in the
             target therapeutic range.

          4. Patient has atrial fibrillation.

          5. Patient has had an acute myocardial infarction within 60 days prior to index
             procedure.

          6. Patient has had or plans to have any major surgical procedure (i.e. intraabdominal or
             intrathoracic surgery or any surgery/interventional procedure involving cardiac or
             vascular system) within 30 days of the index procedure.

          7. Patient has a history of major ipsilateral stroke.

          8. Patient has &gt;60% carotid stenosis contralateral to the target lesion requiring
             treatment prior to completion of thes study-required 12 month follow-up.

          9. Patient has a modified Rankin Scale of &gt;2 or has another neurological deficit not due
             to stroke that may confound the neurological patient assessments.

         10. Patient has chronic renal insufficiency (serum creatinine ≥2.5 mg/dL) or has a history
             of severe hepatic impairment, malignant hypertension, and/or is morbidly obese.

         11. Patient has platelet count &lt;100,000/μL.

         12. Patient has known sensitivity to heparin or previous incidence of Heparin‐Induced
             Thrombocytopenia (HIT) type II.

         13. Patient has contraindication to standard of care study medications, including
             antiplatelet therapy.

         14. Patient has known sensitivity to contrast media that cannot be adequately controlled
             with premedication.

         15. Patient has known bleeding diathesis or hypercoagulable state or refuses blood
             transfusions.

         16. Patient has intracranial pathology that, in the opinion of the investigator, makes the
             patient inappropriate for study participation (e.g. brain tumor, AVM, cerebral
             aneurysm, cerebral vascular disease [microangiopathy or large vessel], etc.) or would
             confound neurological evaluation.

         17. Patient had intracranial hemorrhage within the last 90 days.

         18. Patient is currently enrolled in another investigational study protocol and has not
             completed its primary endpoint or that will confound the current study endpoints.
             Patients who are involved in the long‐term surveillance of a clinical study are
             eligible.

         19. Patient suffers from confusion or dementia or is unable or unwilling to cooperate with
             the study requirements and/or follow‐up procedures.

         20. Patient has a known, unresolved history of drug use or alcohol dependency.

         21. Patient has an active infection.

         22. Patient has renal failure and/or is on dialysis.

         23. Patient has documented uncontrolled diabetes.

         24. Patient is pregnant.

        Angiographic Exclusion Criteria

        A patient is not eligible for enrollment in the study if he/she meets any of the following
        angiographic exclusion criteria:

          1. Patient has a total occlusion of the target carotid arteries (i.e., CCA or ICA).

          2. Patient has a previously placed stent in the ipsilateral carotid artery.

          3. Patient has severe lesion calcification or vascular tortuosity that may preclude the
             safe introduction of the sheath, guiding catheter, embolic protection system, or
             stent.

          4. Patient has the presence of mobile filling defect or thrombus in target vessel.

          5. Patient has occlusion or presence of &quot;string sign&quot; of the target vessel.

          6. Patient has carotid (intracranial) stenosis located distal to target stenosis that is
             more severe than target stenosis.

          7. Patient has known mobile plaque or thrombus in the aortic arch.

          8. Patient has a type III aortic arch.

          9. Patient in whom femoral access is not possible.

         10. Patient has intracranial arteriovenous malformations of the territory of the target
             carotid artery.

         11. Patient has an aneurysm in the territory of the target carotid artery that requires
             treatment within 12 months.

         12. Patient's ipsilateral carotid artery has 2 or more 90 degree bends in the target
             landing zone.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adnan Siddiqui, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Buffalo - Neurosurgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chris Metzger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wellmont CVA Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Schneider, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente Moanalua Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Walters</last_name>
    <phone>714.247.8000</phone>
    <email>amy.walters@microvention.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Nguyen</last_name>
    <phone>714.247.8000</phone>
    <email>david.nguyen@microvention.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Abrazo Arizona Heart Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Osgood</last_name>
      <phone>602-604-5021</phone>
      <email>taosgood@abrazohealth.com</email>
    </contact>
    <investigator>
      <last_name>Venkatesh Ramaiah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ayman Jamal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Renata Schwartz</last_name>
      <phone>602-251-8890</phone>
      <email>rschwartz@iasishealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Rick Heuser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente - Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Liu</last_name>
      <phone>323-246-2751</phone>
      <email>Catherine.L.Lui@kp.org</email>
    </contact>
    <contact_backup>
      <last_name>Jee Yang</last_name>
      <email>jee.s.yang@kp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Lei T. Feng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kuo Chao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sutter Health Institute - Sacramento</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Linda Dodrill</last_name>
      <phone>916-454-6973</phone>
      <email>DodrilL@sutterhealth.org</email>
    </contact>
    <investigator>
      <last_name>Lofti Hacein-Bey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bahram Varjavand, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Diego VA Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hailey Hirschfeld</last_name>
      <phone>858-552-4352</phone>
      <email>hhirschfeld@vapop.ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Emma Schlueter</last_name>
      <email>eschlueter@vapop.ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>John Lane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Barleben, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MicroVention, Inc.</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <zip>92832</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Nguyen</last_name>
      <phone>714-247-8131</phone>
      <email>david.nguyen@microvention.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radiology Imaging Associates</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joanna Snead</last_name>
      <phone>720-493-3403</phone>
      <email>joanna.snead@riaco.com</email>
    </contact>
    <investigator>
      <last_name>Richard Bellon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Don Frei, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise McLellan</last_name>
      <phone>203-737-7166</phone>
      <email>louise.mclellan@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Charles Matouk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Mena, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suman Singh</last_name>
      <phone>202-277-8475</phone>
      <email>suman.singh@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Nelson Bernardo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edward Woo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyerly Baptist Neurosurgery</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Ebreo</last_name>
      <phone>904-398-0125</phone>
      <phone_ext>1434</phone_ext>
      <email>nancy.ebreo@bmcjax.com</email>
    </contact>
    <investigator>
      <last_name>Ricardo Hanel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Savageau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Moanalua Medical Center - Specialty Clinic</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Peter Schneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prairie Education &amp; Research Cooperative</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelse Mather</last_name>
      <phone>217-492-9100</phone>
      <phone_ext>122</phone_ext>
      <email>kmather@prairieresearch.com</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nilesh Gowsami, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baptist Health Lexington</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Breathitt</last_name>
      <phone>859-260-6344</phone>
      <email>lbreathitt@bhsi.com</email>
    </contact>
    <contact_backup>
      <last_name>Sara Renfrow</last_name>
      <email>Sara.renfrow@bhsi.com</email>
    </contact_backup>
    <investigator>
      <last_name>Christian Ramsey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Curtis Givens, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Jones, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Newman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville / Norton Neuroscience Institute</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ann Jerde</last_name>
      <phone>502-852-5251</phone>
      <email>ann.jerde@louisville.edu</email>
    </contact>
    <contact_backup>
      <last_name>Debbie Ritchey</last_name>
      <phone>502-446-8544</phone>
      <email>Debbie.Ritchey@nortonhealthcare.org</email>
    </contact_backup>
    <investigator>
      <last_name>Rob James, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shervin Dashti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tom Yao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bryan Heart</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosalie Saalfeld</last_name>
      <phone>402-483-3294</phone>
      <email>rose.saalfeld@bryanheart.com</email>
    </contact>
    <investigator>
      <last_name>Robert Hibbard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Darthmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Arnaio</last_name>
      <phone>603-650-7966</phone>
      <email>wendy.h.aarnio@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Rick Powell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeanwan Kang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Stone, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philip Goodney, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bjoern Suckow, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Overlook Medical Center</name>
      <address>
        <city>Summit</city>
        <state>New Jersey</state>
        <zip>07901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Betty Merveil-Ceneus</last_name>
      <phone>908-522-6279</phone>
      <email>Betty.Merveil-Ceneus@atlantichealth.org</email>
    </contact>
    <investigator>
      <last_name>Mark Kumar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical College</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Graca</last_name>
      <phone>518-262-5938</phone>
      <email>GracaL@mail.amc.edu</email>
    </contact>
    <investigator>
      <last_name>Alan Boulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonna Sakowski</last_name>
      <phone>716-218-1000</phone>
      <phone_ext>7276</phone_ext>
      <email>jsakowski@ubns.com</email>
    </contact>
    <investigator>
      <last_name>Elad Levy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adnan Siddiqui, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kenneth Snyder, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucia Mannini, MPH</last_name>
      <phone>212-241-2524</phone>
      <email>lucia.mannini@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Johanna Fifi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>J. Mocco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center / New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ormarys Castellanos</last_name>
      <phone>212-342-3480</phone>
      <email>oc2207@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kate Dalton</last_name>
      <phone>347-514-3366</phone>
      <email>keb2114@cumc.columbia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Anthony Pucillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ajay J. Kirtane, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philip Green, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Feinstein Institute for Medical Research</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristie Coleman</last_name>
      <phone>212-434-3878</phone>
      <email>kcoleman1@northwell.edu</email>
    </contact>
    <contact_backup>
      <last_name>Christina Brennan</last_name>
      <email>Cbrennan@NSHS.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mitchell Weinberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marlene Baumeister</last_name>
      <phone>631-444-1610</phone>
      <email>marlene.baumeister@stonybrookmedicine.edu</email>
    </contact>
    <investigator>
      <last_name>David Fiorella, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NC Heart and Vascular Research / Rex Hospital</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamal Moss</last_name>
      <phone>919-787-5380</phone>
      <phone_ext>1018563</phone_ext>
      <email>jmoss@nchvresearch.com</email>
    </contact>
    <investigator>
      <last_name>Ravish Sachar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>George Adams, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Zidar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Hook, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Novant Health Forsyth Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Hutchinson</last_name>
      <phone>336-718-5871</phone>
      <email>emhutchison@novanthealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Susan Donahue</last_name>
      <phone>336-718-5810</phone>
      <email>sdonahue@novanthealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Don Heck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Morry Brown, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Holy Spirit Cardiology Research</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Grassmeyer</last_name>
      <phone>717-724-6302</phone>
      <email>nfgrassmyer@geisinger.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albert Einstein Healthcare Network</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kinnari Murthy</last_name>
      <phone>215-456-1959</phone>
      <email>murthyk@einstein.edu</email>
    </contact>
    <investigator>
      <last_name>Jon George, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sean Janzer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lankenau Institute for Medical Research</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne Chikowski</last_name>
      <phone>484-476-8579</phone>
      <email>ChikowskiA@MLHS.ORG</email>
    </contact>
    <investigator>
      <last_name>William Gray, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Berks Cardiologists</name>
      <address>
        <city>Wyomissing</city>
        <state>Pennsylvania</state>
        <zip>19610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Petersheim</last_name>
      <phone>610-685-4843</phone>
      <email>kpetersheim@berkscardiologists.com</email>
    </contact>
    <investigator>
      <last_name>Guy Piegari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Black Hills Cardiovascular Research / Regional Health Hospital</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirstin Stauffacher</last_name>
      <phone>605-755-3764</phone>
      <email>kstauffach@regionalhealth.com</email>
    </contact>
    <investigator>
      <last_name>Joseph Tuma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bhaskar Purushottam, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Central Heart Institute</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patty Eisenbraun</last_name>
      <phone>605-977-5336</phone>
      <email>peisenbraun@ncheart.com</email>
    </contact>
    <contact_backup>
      <last_name>Robin Farley</last_name>
      <phone>607-977-5000</phone>
      <email>research@ncheart.com</email>
    </contact_backup>
    <investigator>
      <last_name>J. Michael Bacharach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tommy Reynolds, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dustin Weiss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josh Lester</last_name>
      <phone>423-230-5642</phone>
      <email>jlester@mycva.com</email>
    </contact>
    <investigator>
      <last_name>Chris Metzger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shardul Nagre, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Aziz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tennova Healthcare - Turkey Creek Medical Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37934</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Polk</last_name>
      <phone>865-218-7535</phone>
      <email>beth.polk@tennova.com</email>
    </contact>
    <investigator>
      <last_name>Malcolm Foster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kirti Singh, MBA</last_name>
      <phone>409-772-5662</phone>
      <email>ksingh@utmb.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Silva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MultiCare Institute for Research and Innovation</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janey Barnhart</last_name>
      <phone>253-403-7258</phone>
      <email>meredith.barnhart@multicare.org</email>
    </contact>
    <investigator>
      <last_name>Brian Kott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dennis Wang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2016</study_first_submitted>
  <study_first_submitted_qc>January 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2016</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stent</keyword>
  <keyword>stenosis</keyword>
  <keyword>artery</keyword>
  <keyword>carotid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

